The government of India has allowed the exports of 13 pharmaceutical formulations, including those made of Vitamin B6, B12 and B1 under advance licenses issued on or before March 3. It also permitted exports of the restricted 13 active pharmaceutical ingredients (API) and 13 formulations is allowed from units in special economic zones (SEZ).
Previously, the Directorate General of Foreign Trade (DGFT) had restricted the exports of 26 active pharmaceutical ingredients (API) and formulations on March 3 to ensure to ensure there would be no shortage of drugs in India due to the lockdown in Hubei ~ province, China, a major source for these raw materials that has also been the epicentre of the coronavirus outbreak.